Patents by Inventor Stephane Gingras

Stephane Gingras has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimido[4,5-B]indole derivatives and use thereof in the expansion of hematopoietic stem cells
    Patent number: 10336747
    Abstract: Pyrimido[4,5-b]indole derivatives are provided. These compounds are useful to expand hematopoietic stem cell populations, particularly, human hematopoietic stem cell populations. The compounds are also useful in the medical treatment of diseases that involve hematopoietic stem cells.
    Type: Grant
    Filed: December 2, 2016
    Date of Patent: July 2, 2019
    Assignee: UNIVERSITÉ DE MONTRÉAL
    Inventors: Guy Sauvageau, Yves Gareau, Rejean Ruel, Stephane Gingras, Iman Fares
  • Processes for the preparation of antiviral 7-azaindole derivatives
    Patent number: 6884889
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of azaindole piperazine diamide derivatives of the formula These azaindole piperazine diamide derivatives, among other things, are useful as therapeutic agents for the treatment of HIV and AIDS.
    Type: Grant
    Filed: March 24, 2003
    Date of Patent: April 26, 2005
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Nachimuthu Soundararajan, Serge Benoit, Stephane Gingras
  • Processes for the preparation of antiviral 7-azaindole derivatives
    Publication number: 20040044025
    Abstract: Provided are processes and synthetic intermediates useful for the preparation of azaindole piperazine diamide derivatives of the formula 1
    Type: Application
    Filed: March 24, 2003
    Publication date: March 4, 2004
    Inventors: Nachimuthu Soundararajan, Serge Benoit, Stephane Gingras